Listed

Madrigal Pharmaceuticals, Inc.

MDGLNasdaqCIK 1157601HealthcareFiscal year ends Dec 31

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$364.3m, Q2 FY2026
Operating income−$56.3m, Q2 FY2026
Net income−$57.9m, Q2 FY2026
Madrigal Pharmaceuticals, Inc., income statement, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Revenue$m0.0Revenue, Q3 FY2023, three months to 2023-09-30$0. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2024-10-31, accession 0001628280-24-044445.Report this figure0.0Revenue, Q4 FY2023, three months to 2023-12-31$0. XBRL concept us-gaap:Revenues. 10-K filed 2024-02-28, accession 0001628280-24-007376.Report this figure0.0Revenue, Q1 FY2024, three months to 2024-03-31$0. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-05-01, accession 0001628280-25-021356.Report this figure14.6Revenue, Q2 FY2024, three months to 2024-06-30$14.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-08-05, accession 0001628280-25-037613.Report this figure62.2Revenue, Q3 FY2024, three months to 2024-09-30$62.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-04, accession 0001628280-25-048559.Report this figure103Revenue, Q4 FY2024, three months to 2024-12-31$103.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-19, accession 0001628280-26-009514. Derived: 12-month figure less the 9-month figure.Report this figure137Revenue, Q1 FY2025, three months to 2025-03-31$137.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-06, accession 0001628280-26-030947.Report this figure213Revenue, Q2 FY2025, three months to 2025-06-30$212.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-07-30, accession 0001628280-26-050845.Report this figure287Revenue, Q3 FY2025, three months to 2025-09-30$287.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-04, accession 0001628280-25-048559.Report this figure321Revenue, Q4 FY2025, three months to 2025-12-31$321.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-19, accession 0001628280-26-009514. Derived: 12-month figure less the 9-month figure.Report this figure311Revenue, Q1 FY2026, three months to 2026-03-31$311.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-06, accession 0001628280-26-030947.Report this figure364Revenue, Q2 FY2026, three months to 2026-06-30$364.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-07-30, accession 0001628280-26-050845.Report this figure
Cost of revenue$mnot reportednot reported0.0Cost of revenue, Q1 FY2024, three months to 2024-03-31$0. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-05-01, accession 0001628280-25-021356.Report this figurenot reportednot reportednot reported4.5Cost of revenue, Q1 FY2025, three months to 2025-03-31$4.5m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-05-01, accession 0001628280-25-021356.Report this figurenot reportednot reportednot reportednot reportednot reported
Selling, general and administrative$m27.6Selling, general and administrative, Q3 FY2023, three months to 2023-09-30$27.6m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2024-10-31, accession 0001628280-24-044445.Report this figure46.5Selling, general and administrative, Q4 FY2023, three months to 2023-12-31$46.5m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2026-02-19, accession 0001628280-26-009514. Derived: 12-month figure less the 9-month figure.Report this figure80.8Selling, general and administrative, Q1 FY2024, three months to 2024-03-31$80.8m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-05-01, accession 0001628280-25-021356.Report this figure105Selling, general and administrative, Q2 FY2024, three months to 2024-06-30$105.4m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-08-05, accession 0001628280-25-037613.Report this figure108Selling, general and administrative, Q3 FY2024, three months to 2024-09-30$107.6m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-11-04, accession 0001628280-25-048559.Report this figure141Selling, general and administrative, Q4 FY2024, three months to 2024-12-31$141.2m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2026-02-19, accession 0001628280-26-009514. Derived: 12-month figure less the 9-month figure.Report this figure168Selling, general and administrative, Q1 FY2025, three months to 2025-03-31$167.9m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-05-06, accession 0001628280-26-030947.Report this figure197Selling, general and administrative, Q2 FY2025, three months to 2025-06-30$196.9m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-07-30, accession 0001628280-26-050845.Report this figure209Selling, general and administrative, Q3 FY2025, three months to 2025-09-30$209.1m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-11-04, accession 0001628280-25-048559.Report this figure240Selling, general and administrative, Q4 FY2025, three months to 2025-12-31$240.0m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2026-02-19, accession 0001628280-26-009514. Derived: 12-month figure less the 9-month figure.Report this figure269Selling, general and administrative, Q1 FY2026, three months to 2026-03-31$268.5m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-05-06, accession 0001628280-26-030947.Report this figure289Selling, general and administrative, Q2 FY2026, three months to 2026-06-30$289.4m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-07-30, accession 0001628280-26-050845.Report this figure
Operating income$m(98.5)Operating income, Q3 FY2023, three months to 2023-09-30−$98.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-10-31, accession 0001628280-24-044445.Report this figure(117)Operating income, Q4 FY2023, three months to 2023-12-31−$117.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2024-02-28, accession 0001628280-24-007376.Report this figure(152)Operating income, Q1 FY2024, three months to 2024-03-31−$152.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-01, accession 0001628280-25-021356.Report this figure(163)Operating income, Q2 FY2024, three months to 2024-06-30−$162.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-08-05, accession 0001628280-25-037613.Report this figure(116)Operating income, Q3 FY2024, three months to 2024-09-30−$116.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-04, accession 0001628280-25-048559.Report this figure(67.0)Operating income, Q4 FY2024, three months to 2024-12-31−$67.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-19, accession 0001628280-26-009514. Derived: 12-month figure less the 9-month figure.Report this figure(79.3)Operating income, Q1 FY2025, three months to 2025-03-31−$79.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-06, accession 0001628280-26-030947.Report this figure(47.2)Operating income, Q2 FY2025, three months to 2025-06-30−$47.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-07-30, accession 0001628280-26-050845.Report this figure(114)Operating income, Q3 FY2025, three months to 2025-09-30−$114.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-04, accession 0001628280-25-048559.Report this figure(59.6)Operating income, Q4 FY2025, three months to 2025-12-31−$59.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-19, accession 0001628280-26-009514. Derived: 12-month figure less the 9-month figure.Report this figure(92.7)Operating income, Q1 FY2026, three months to 2026-03-31−$92.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-06, accession 0001628280-26-030947.Report this figure(56.3)Operating income, Q2 FY2026, three months to 2026-06-30−$56.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-07-30, accession 0001628280-26-050845.Report this figure
Interest expense$m3.5Interest expense, Q3 FY2023, three months to 2023-09-30$3.5m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2024-10-31, accession 0001628280-24-044445.Report this figure4.0Interest expense, Q4 FY2023, three months to 2023-12-31$4.0m. XBRL concept us-gaap:InterestExpense. 10-K filed 2024-02-28, accession 0001628280-24-007376.Report this figure3.8Interest expense, Q1 FY2024, three months to 2024-03-31$3.8m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2025-05-01, accession 0001628280-25-021356.Report this figure3.7Interest expense, Q2 FY2024, three months to 2024-06-30$3.7m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2024-08-07, accession 0001628280-24-035400.Report this figure3.7Interest expense, Q3 FY2024, three months to 2024-09-30$3.7m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2024-10-31, accession 0001628280-24-044445.Report this figure3.5Interest expense, Q4 FY2024, three months to 2024-12-31$3.5m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-K filed 2026-02-19, accession 0001628280-26-009514. Derived: 12-month figure less the 9-month figure.Report this figure3.3Interest expense, Q1 FY2025, three months to 2025-03-31$3.3m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2025-05-01, accession 0001628280-25-021356.Report this figure3.3Interest expense, Q2 FY2025, three months to 2025-06-30$3.3m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-07-30, accession 0001628280-26-050845.Report this figure7.5Interest expense, Q3 FY2025, three months to 2025-09-30$7.5m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-11-04, accession 0001628280-25-048559.Report this figure8.3Interest expense, Q4 FY2025, three months to 2025-12-31$8.3m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-K filed 2026-02-19, accession 0001628280-26-009514. Derived: 12-month figure less the 9-month figure.Report this figure7.8Interest expense, Q1 FY2026, three months to 2026-03-31$7.8m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-05-06, accession 0001628280-26-030947.Report this figure7.9Interest expense, Q2 FY2026, three months to 2026-06-30$7.9m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-07-30, accession 0001628280-26-050845.Report this figure
Net income$m(98.7)Net income, Q3 FY2023, three months to 2023-09-30−$98.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-10-31, accession 0001628280-24-044445.Report this figure(112)Net income, Q4 FY2023, three months to 2023-12-31−$112.2m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2024-02-28, accession 0001628280-24-007376.Report this figure(148)Net income, Q1 FY2024, three months to 2024-03-31−$147.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-04, accession 0001628280-25-048559.Report this figure(152)Net income, Q2 FY2024, three months to 2024-06-30−$152.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-04, accession 0001628280-25-048559.Report this figure(107)Net income, Q3 FY2024, three months to 2024-09-30−$107.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-04, accession 0001628280-25-048559.Report this figure(59.4)Net income, Q4 FY2024, three months to 2024-12-31−$59.4m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-19, accession 0001628280-26-009514. Derived: 12-month figure less the 9-month figure.Report this figure(73.2)Net income, Q1 FY2025, three months to 2025-03-31−$73.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-07-30, accession 0001628280-26-050845.Report this figure(42.3)Net income, Q2 FY2025, three months to 2025-06-30−$42.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-07-30, accession 0001628280-26-050845.Report this figure(114)Net income, Q3 FY2025, three months to 2025-09-30−$114.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-04, accession 0001628280-25-048559.Report this figure(58.6)Net income, Q4 FY2025, three months to 2025-12-31−$58.6m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-19, accession 0001628280-26-009514. Derived: 12-month figure less the 9-month figure.Report this figure(94.4)Net income, Q1 FY2026, three months to 2026-03-31−$94.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-07-30, accession 0001628280-26-050845.Report this figure(57.9)Net income, Q2 FY2026, three months to 2026-06-30−$57.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-07-30, accession 0001628280-26-050845.Report this figure
Diluted EPS$ per share(5.34)Diluted EPS, Q3 FY2023, three months to 2023-09-30−$5.34 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-10-31, accession 0001628280-24-044445.Report this figure(5.68)Diluted EPS, Q4 FY2023, three months to 2023-12-31−$5.68 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2024-02-28, accession 0001628280-24-007376.Report this figure(7.38)Diluted EPS, Q1 FY2024, three months to 2024-03-31−$7.38 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-05-01, accession 0001628280-25-021356.Report this figure(7.10)Diluted EPS, Q2 FY2024, three months to 2024-06-30−$7.10 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-08-05, accession 0001628280-25-037613.Report this figure(4.92)Diluted EPS, Q3 FY2024, three months to 2024-09-30−$4.92 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-04, accession 0001628280-25-048559.Report this figurenot reported(2.61)Diluted EPS, Q1 FY2025, three months to 2025-03-31−$2.61 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-06, accession 0001628280-26-030947.Report this figure(1.50)Diluted EPS, Q2 FY2025, three months to 2025-06-30−$1.50 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-07-30, accession 0001628280-26-050845.Report this figure(4.01)Diluted EPS, Q3 FY2025, three months to 2025-09-30−$4.01 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-07-30, accession 0001628280-26-050845.Report this figurenot reported(3.25)Diluted EPS, Q1 FY2026, three months to 2026-03-31−$3.25 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-06, accession 0001628280-26-030947.Report this figure(1.99)Diluted EPS, Q2 FY2026, three months to 2026-06-30−$1.99 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-07-30, accession 0001628280-26-050845.Report this figure
Basic EPS$ per share(5.34)Basic EPS, Q3 FY2023, three months to 2023-09-30−$5.34 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-10-31, accession 0001628280-24-044445.Report this figure(5.68)Basic EPS, Q4 FY2023, three months to 2023-12-31−$5.68 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-K filed 2024-02-28, accession 0001628280-24-007376.Report this figure(7.38)Basic EPS, Q1 FY2024, three months to 2024-03-31−$7.38 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-05-01, accession 0001628280-25-021356.Report this figure(7.10)Basic EPS, Q2 FY2024, three months to 2024-06-30−$7.10 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-08-05, accession 0001628280-25-037613.Report this figure(4.92)Basic EPS, Q3 FY2024, three months to 2024-09-30−$4.92 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-04, accession 0001628280-25-048559.Report this figurenot reported(2.61)Basic EPS, Q1 FY2025, three months to 2025-03-31−$2.61 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-06, accession 0001628280-26-030947.Report this figure(1.50)Basic EPS, Q2 FY2025, three months to 2025-06-30−$1.50 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-07-30, accession 0001628280-26-050845.Report this figure(4.01)Basic EPS, Q3 FY2025, three months to 2025-09-30−$4.01 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-07-30, accession 0001628280-26-050845.Report this figurenot reported(3.25)Basic EPS, Q1 FY2026, three months to 2026-03-31−$3.25 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-06, accession 0001628280-26-030947.Report this figure(1.99)Basic EPS, Q2 FY2026, three months to 2026-06-30−$1.99 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-07-30, accession 0001628280-26-050845.Report this figure

Balance sheet

Cash and equivalents$292.7m, Q2 FY2026
Long-term debt$340.8m, Q2 FY2026
Shareholders' equity$523.7m, Q2 FY2026
Madrigal Pharmaceuticals, Inc., balance sheet, quarterly
Line itemUnitQ3 FY20232023-09-30FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Cash and equivalents$m62.1Cash and equivalents, Q3 FY2023, at 2023-09-30$62.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2023-11-06, accession 0001193125-23-270803.Report this figure99.9Cash and equivalents, FY2023, at 2023-12-31$99.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2025-02-26, accession 0001628280-25-007980.Report this figure623Cash and equivalents, Q1 FY2024, at 2024-03-31$622.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-05-07, accession 0001628280-24-020865.Report this figure495Cash and equivalents, Q2 FY2024, at 2024-06-30$494.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-08-07, accession 0001628280-24-035400.Report this figure233Cash and equivalents, Q3 FY2024, at 2024-09-30$232.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-10-31, accession 0001628280-24-044445.Report this figure100Cash and equivalents, FY2024, at 2024-12-31$100.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-02-19, accession 0001628280-26-009514.Report this figure184Cash and equivalents, Q1 FY2025, at 2025-03-31$183.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-05-01, accession 0001628280-25-021356.Report this figure186Cash and equivalents, Q2 FY2025, at 2025-06-30$186.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-08-05, accession 0001628280-25-037613.Report this figure296Cash and equivalents, Q3 FY2025, at 2025-09-30$295.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-04, accession 0001628280-25-048559.Report this figure199Cash and equivalents, FY2025, at 2025-12-31$198.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-07-30, accession 0001628280-26-050845.Report this figure227Cash and equivalents, Q1 FY2026, at 2026-03-31$227.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-06, accession 0001628280-26-030947.Report this figure293Cash and equivalents, Q2 FY2026, at 2026-06-30$292.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-07-30, accession 0001628280-26-050845.Report this figure
Current assets$m235Current assets, Q3 FY2023, at 2023-09-30$235.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2023-11-06, accession 0001193125-23-270803.Report this figure637Current assets, FY2023, at 2023-12-31$637.3m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-02-26, accession 0001628280-25-007980.Report this figure1,074Current assets, Q1 FY2024, at 2024-03-31$1.07bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-05-07, accession 0001628280-24-020865.Report this figure1,092Current assets, Q2 FY2024, at 2024-06-30$1.09bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-08-07, accession 0001628280-24-035400.Report this figure1,064Current assets, Q3 FY2024, at 2024-09-30$1.06bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-10-31, accession 0001628280-24-044445.Report this figure1,033Current assets, FY2024, at 2024-12-31$1.03bn. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-02-19, accession 0001628280-26-009514.Report this figure988Current assets, Q1 FY2025, at 2025-03-31$988.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-01, accession 0001628280-25-021356.Report this figure1,003Current assets, Q2 FY2025, at 2025-06-30$1.00bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-08-05, accession 0001628280-25-037613.Report this figure1,347Current assets, Q3 FY2025, at 2025-09-30$1.35bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-11-04, accession 0001628280-25-048559.Report this figure1,246Current assets, FY2025, at 2025-12-31$1.25bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-07-30, accession 0001628280-26-050845.Report this figure1,182Current assets, Q1 FY2026, at 2026-03-31$1.18bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-06, accession 0001628280-26-030947.Report this figure1,199Current assets, Q2 FY2026, at 2026-06-30$1.20bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-07-30, accession 0001628280-26-050845.Report this figure
Total assets$m238Total assets, Q3 FY2023, at 2023-09-30$238.0m. XBRL concept us-gaap:Assets. 10-Q filed 2023-11-06, accession 0001193125-23-270803.Report this figure641Total assets, FY2023, at 2023-12-31$640.5m. XBRL concept us-gaap:Assets. 10-K filed 2025-02-26, accession 0001628280-25-007980.Report this figure1,082Total assets, Q1 FY2024, at 2024-03-31$1.08bn. XBRL concept us-gaap:Assets. 10-Q filed 2024-05-07, accession 0001628280-24-020865.Report this figure1,100Total assets, Q2 FY2024, at 2024-06-30$1.10bn. XBRL concept us-gaap:Assets. 10-Q filed 2024-08-07, accession 0001628280-24-035400.Report this figure1,073Total assets, Q3 FY2024, at 2024-09-30$1.07bn. XBRL concept us-gaap:Assets. 10-Q filed 2024-10-31, accession 0001628280-24-044445.Report this figure1,042Total assets, FY2024, at 2024-12-31$1.04bn. XBRL concept us-gaap:Assets. 10-K filed 2026-02-19, accession 0001628280-26-009514.Report this figure997Total assets, Q1 FY2025, at 2025-03-31$996.6m. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-01, accession 0001628280-25-021356.Report this figure1,015Total assets, Q2 FY2025, at 2025-06-30$1.02bn. XBRL concept us-gaap:Assets. 10-Q filed 2025-08-05, accession 0001628280-25-037613.Report this figure1,362Total assets, Q3 FY2025, at 2025-09-30$1.36bn. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-04, accession 0001628280-25-048559.Report this figure1,260Total assets, FY2025, at 2025-12-31$1.26bn. XBRL concept us-gaap:Assets. 10-Q filed 2026-07-30, accession 0001628280-26-050845.Report this figure1,227Total assets, Q1 FY2026, at 2026-03-31$1.23bn. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-06, accession 0001628280-26-030947.Report this figure1,245Total assets, Q2 FY2026, at 2026-06-30$1.24bn. XBRL concept us-gaap:Assets. 10-Q filed 2026-07-30, accession 0001628280-26-050845.Report this figure
Current liabilities$m99.7Current liabilities, Q3 FY2023, at 2023-09-30$99.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2023-11-06, accession 0001193125-23-270803.Report this figure119Current liabilities, FY2023, at 2023-12-31$118.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-02-26, accession 0001628280-25-007980.Report this figure114Current liabilities, Q1 FY2024, at 2024-03-31$114.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-05-07, accession 0001628280-24-020865.Report this figure125Current liabilities, Q2 FY2024, at 2024-06-30$125.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-08-07, accession 0001628280-24-035400.Report this figure178Current liabilities, Q3 FY2024, at 2024-09-30$177.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-10-31, accession 0001628280-24-044445.Report this figure169Current liabilities, FY2024, at 2024-12-31$169.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-02-19, accession 0001628280-26-009514.Report this figure167Current liabilities, Q1 FY2025, at 2025-03-31$167.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-01, accession 0001628280-25-021356.Report this figure197Current liabilities, Q2 FY2025, at 2025-06-30$196.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-08-05, accession 0001628280-25-037613.Report this figure391Current liabilities, Q3 FY2025, at 2025-09-30$391.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-11-04, accession 0001628280-25-048559.Report this figure310Current liabilities, FY2025, at 2025-12-31$310.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-07-30, accession 0001628280-26-050845.Report this figure338Current liabilities, Q1 FY2026, at 2026-03-31$338.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-06, accession 0001628280-26-030947.Report this figure374Current liabilities, Q2 FY2026, at 2026-06-30$374.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-07-30, accession 0001628280-26-050845.Report this figure
Total liabilities$m216Total liabilities, Q3 FY2023, at 2023-09-30$215.7m. XBRL concept us-gaap:Liabilities. 10-Q filed 2023-11-06, accession 0001193125-23-270803.Report this figure235Total liabilities, FY2023, at 2023-12-31$235.2m. XBRL concept us-gaap:Liabilities. 10-K filed 2025-02-26, accession 0001628280-25-007980.Report this figure232Total liabilities, Q1 FY2024, at 2024-03-31$231.5m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-05-07, accession 0001628280-24-020865.Report this figure243Total liabilities, Q2 FY2024, at 2024-06-30$242.7m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-08-07, accession 0001628280-24-035400.Report this figure296Total liabilities, Q3 FY2024, at 2024-09-30$296.1m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-10-31, accession 0001628280-24-044445.Report this figure288Total liabilities, FY2024, at 2024-12-31$287.9m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-02-19, accession 0001628280-26-009514.Report this figure286Total liabilities, Q1 FY2025, at 2025-03-31$286.0m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-05-01, accession 0001628280-25-021356.Report this figure319Total liabilities, Q2 FY2025, at 2025-06-30$319.4m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-08-05, accession 0001628280-25-037613.Report this figure737Total liabilities, Q3 FY2025, at 2025-09-30$736.7m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-11-04, accession 0001628280-25-048559.Report this figure657Total liabilities, FY2025, at 2025-12-31$656.9m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-07-30, accession 0001628280-26-050845.Report this figure684Total liabilities, Q1 FY2026, at 2026-03-31$683.9m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-06, accession 0001628280-26-030947.Report this figure721Total liabilities, Q2 FY2026, at 2026-06-30$720.9m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-07-30, accession 0001628280-26-050845.Report this figure
Long-term debt$m115Long-term debt, Q3 FY2023, at 2023-09-30$114.7m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2023-11-06, accession 0001193125-23-270803.Report this figure115Long-term debt, FY2023, at 2023-12-31$115.5m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-K filed 2025-02-26, accession 0001628280-25-007980.Report this figure116Long-term debt, Q1 FY2024, at 2024-03-31$116.1m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2024-05-07, accession 0001628280-24-020865.Report this figure117Long-term debt, Q2 FY2024, at 2024-06-30$116.6m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2024-08-07, accession 0001628280-24-035400.Report this figure117Long-term debt, Q3 FY2024, at 2024-09-30$117.1m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2024-10-31, accession 0001628280-24-044445.Report this figure118Long-term debt, FY2024, at 2024-12-31$117.6m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-K filed 2026-02-19, accession 0001628280-26-009514.Report this figure118Long-term debt, Q1 FY2025, at 2025-03-31$118.0m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2025-05-01, accession 0001628280-25-021356.Report this figure118Long-term debt, Q2 FY2025, at 2025-06-30$118.4m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2025-08-05, accession 0001628280-25-037613.Report this figure340Long-term debt, Q3 FY2025, at 2025-09-30$339.8m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2025-11-04, accession 0001628280-25-048559.Report this figure340Long-term debt, FY2025, at 2025-12-31$339.9m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2026-07-30, accession 0001628280-26-050845.Report this figure340Long-term debt, Q1 FY2026, at 2026-03-31$340.3m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2026-05-06, accession 0001628280-26-030947.Report this figure341Long-term debt, Q2 FY2026, at 2026-06-30$340.8m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2026-07-30, accession 0001628280-26-050845.Report this figure
Shareholders' equity$m22.2Shareholders' equity, Q3 FY2023, at 2023-09-30$22.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-10-31, accession 0001628280-24-044445.Report this figure405Shareholders' equity, FY2023, at 2023-12-31$405.3m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-02-19, accession 0001628280-26-009514.Report this figure851Shareholders' equity, Q1 FY2024, at 2024-03-31$850.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-04, accession 0001628280-25-048559.Report this figure857Shareholders' equity, Q2 FY2024, at 2024-06-30$857.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-04, accession 0001628280-25-048559.Report this figure777Shareholders' equity, Q3 FY2024, at 2024-09-30$777.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-04, accession 0001628280-25-048559.Report this figure754Shareholders' equity, FY2024, at 2024-12-31$754.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-07-30, accession 0001628280-26-050845.Report this figure711Shareholders' equity, Q1 FY2025, at 2025-03-31$710.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-07-30, accession 0001628280-26-050845.Report this figure696Shareholders' equity, Q2 FY2025, at 2025-06-30$696.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-07-30, accession 0001628280-26-050845.Report this figure626Shareholders' equity, Q3 FY2025, at 2025-09-30$625.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-04, accession 0001628280-25-048559.Report this figure603Shareholders' equity, FY2025, at 2025-12-31$602.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-07-30, accession 0001628280-26-050845.Report this figure543Shareholders' equity, Q1 FY2026, at 2026-03-31$543.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-07-30, accession 0001628280-26-050845.Report this figure524Shareholders' equity, Q2 FY2026, at 2026-06-30$523.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-07-30, accession 0001628280-26-050845.Report this figure

Cash flow

Operating cash flow$23.3m, Q2 FY2026
Capital expenditure$4.3m, Q2 FY2026
Madrigal Pharmaceuticals, Inc., cash flow, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Operating cash flow$m(84.9)Operating cash flow, Q3 FY2023, three months to 2023-09-30−$84.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-10-31, accession 0001628280-24-044445. Derived: 9-month figure less the 6-month figure.Report this figure(79.9)Operating cash flow, Q4 FY2023, three months to 2023-12-31−$79.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-19, accession 0001628280-26-009514. Derived: 12-month figure less the 9-month figure.Report this figure(149)Operating cash flow, Q1 FY2024, three months to 2024-03-31−$149.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-01, accession 0001628280-25-021356.Report this figure(135)Operating cash flow, Q2 FY2024, three months to 2024-06-30−$134.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-05, accession 0001628280-25-037613. Derived: 6-month figure less the 3-month figure.Report this figure(67.0)Operating cash flow, Q3 FY2024, three months to 2024-09-30−$67.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-04, accession 0001628280-25-048559. Derived: 9-month figure less the 6-month figure.Report this figure(104)Operating cash flow, Q4 FY2024, three months to 2024-12-31−$104.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-19, accession 0001628280-26-009514. Derived: 12-month figure less the 9-month figure.Report this figure(88.9)Operating cash flow, Q1 FY2025, three months to 2025-03-31−$88.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-06, accession 0001628280-26-030947.Report this figure(47.1)Operating cash flow, Q2 FY2025, three months to 2025-06-30−$47.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-07-30, accession 0001628280-26-050845. Derived: 6-month figure less the 3-month figure.Report this figure79.9Operating cash flow, Q3 FY2025, three months to 2025-09-30$79.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-04, accession 0001628280-25-048559. Derived: 9-month figure less the 6-month figure.Report this figure(133)Operating cash flow, Q4 FY2025, three months to 2025-12-31−$133.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-19, accession 0001628280-26-009514. Derived: 12-month figure less the 9-month figure.Report this figure(167)Operating cash flow, Q1 FY2026, three months to 2026-03-31−$167.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-06, accession 0001628280-26-030947.Report this figure23.3Operating cash flow, Q2 FY2026, three months to 2026-06-30$23.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-07-30, accession 0001628280-26-050845. Derived: 6-month figure less the 3-month figure.Report this figure
Capital expenditure$m0.3Capital expenditure, Q3 FY2023, three months to 2023-09-30$339.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2024-10-31, accession 0001628280-24-044445. Derived: 9-month figure less the 6-month figure.Report this figure1.0Capital expenditure, Q4 FY2023, three months to 2023-12-31$1.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-19, accession 0001628280-26-009514. Derived: 12-month figure less the 9-month figure.Report this figure0.4Capital expenditure, Q1 FY2024, three months to 2024-03-31$357.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-05-01, accession 0001628280-25-021356.Report this figure0.1Capital expenditure, Q2 FY2024, three months to 2024-06-30$131.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-08-05, accession 0001628280-25-037613. Derived: 6-month figure less the 3-month figure.Report this figure0.8Capital expenditure, Q3 FY2024, three months to 2024-09-30$779.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-04, accession 0001628280-25-048559. Derived: 9-month figure less the 6-month figure.Report this figure0.2Capital expenditure, Q4 FY2024, three months to 2024-12-31$195.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-19, accession 0001628280-26-009514. Derived: 12-month figure less the 9-month figure.Report this figure0.0Capital expenditure, Q1 FY2025, three months to 2025-03-31$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-06, accession 0001628280-26-030947.Report this figure0.0Capital expenditure, Q2 FY2025, three months to 2025-06-30$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-07-30, accession 0001628280-26-050845. Derived: 6-month figure less the 3-month figure.Report this figure0.9Capital expenditure, Q3 FY2025, three months to 2025-09-30$857.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-04, accession 0001628280-25-048559. Derived: 9-month figure less the 6-month figure.Report this figure(0.4)Capital expenditure, Q4 FY2025, three months to 2025-12-31−$390.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-19, accession 0001628280-26-009514. Derived: 12-month figure less the 9-month figure.Report this figure3.8Capital expenditure, Q1 FY2026, three months to 2026-03-31$3.8m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-06, accession 0001628280-26-030947.Report this figure4.3Capital expenditure, Q2 FY2026, three months to 2026-06-30$4.3m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-07-30, accession 0001628280-26-050845. Derived: 6-month figure less the 3-month figure.Report this figure

Shares

Diluted shares (weighted)29.15m, Q2 FY2026
Madrigal Pharmaceuticals, Inc., shares, quarterly
Line itemUnitQ1 FY20232023-03-31Q2 FY20232023-06-30Q3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q1 FY20262026-03-31Q2 FY20262026-06-30
Diluted shares (weighted)m shares18.2Diluted shares (weighted), Q1 FY2023, three months to 2023-03-3118,187,924 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-05-07, accession 0001628280-24-020865.Report this figure18.3Diluted shares (weighted), Q2 FY2023, three months to 2023-06-3018,310,952 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-08-07, accession 0001628280-24-035400.Report this figure18.5Diluted shares (weighted), Q3 FY2023, three months to 2023-09-3018,476,414 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-10-31, accession 0001628280-24-044445.Report this figure19.8Diluted shares (weighted), Q4 FY2023, three months to 2023-12-3119,760,842 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-K filed 2024-02-28, accession 0001628280-24-007376.Report this figure20.0Diluted shares (weighted), Q1 FY2024, three months to 2024-03-3120,001,569 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-05-01, accession 0001628280-25-021356.Report this figure21.4Diluted shares (weighted), Q2 FY2024, three months to 2024-06-3021,402,646 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-08-05, accession 0001628280-25-037613.Report this figure21.7Diluted shares (weighted), Q3 FY2024, three months to 2024-09-3021,745,929 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-04, accession 0001628280-25-048559.Report this figure28.1Diluted shares (weighted), Q1 FY2025, three months to 2025-03-3128,085,234 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-06, accession 0001628280-26-030947.Report this figure28.2Diluted shares (weighted), Q2 FY2025, three months to 2025-06-3028,232,604 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-07-30, accession 0001628280-26-050845.Report this figure28.5Diluted shares (weighted), Q3 FY2025, three months to 2025-09-3028,508,089 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-07-30, accession 0001628280-26-050845.Report this figure29.0Diluted shares (weighted), Q1 FY2026, three months to 2026-03-3129,032,422 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-06, accession 0001628280-26-030947.Report this figure29.1Diluted shares (weighted), Q2 FY2026, three months to 2026-06-3029,145,271 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-07-30, accession 0001628280-26-050845.Report this figure

Shares outstanding: 23.10mShares outstanding, period not labelled, at 2026-07-2723,104,126 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-07-30, accession 0001628280-26-050845.Report this figure at Jul 27, 2026, from the cover of the 10-Q filed Jul 30, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:34 ET. Listed shows no prices and gives no investment advice.